Original Research
Published on 30 Aug 2022
MRI radiomics predicts progression-free survival in prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.974257
- 3,758 views
- 6 citations
Type at least 3 characters
1,560 articles
Articles
Original Research
Published on 30 Aug 2022
SHMT2 regulates serine metabolism to promote the progression and immunosuppression of papillary renal cell carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.914332
- 3,482 views
- 7 citations
Original Research
Published on 26 Aug 2022
Acidic urine is associated with poor prognosis in patients with bladder cancer undergoing radical cystectomy
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.964571
- 2,849 views
- 1 citation
Original Research
Published on 26 Aug 2022
MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.971344
- 2,098 views
- 10 citations
Original Research
Published on 26 Aug 2022
Machine learning prediction of prostate cancer from transrectal ultrasound video clips
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.948662
- 3,578 views
- 8 citations
Original Research
Published on 26 Aug 2022
Establishing a prognostic model of ferroptosis- and immune-related signatures in kidney cancer: A study based on TCGA and ICGC databases
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.931383
- 2,709 views
- 2 citations
Systematic Review
Published on 19 Aug 2022
Associations of MDM2 rs2279744 and TP53 rs1042522 polymorphisms with cervical cancer risk: A meta-analysis and systematic review
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.973077
- 2,536 views
- 4 citations
Original Research
Published on 19 Aug 2022
Monocytes acquire prostate cancer specific chromatin conformations upon indirect co-culture with prostate cancer cells
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.990842
- 2,053 views
- 3 citations
Mini Review
Published on 19 Aug 2022
IL-8 and its role as a potential biomarker of resistance to anti-angiogenic agents and immune checkpoint inhibitors in metastatic renal cell carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.990568
- 4,733 views
- 12 citations
Original Research
Published on 19 Aug 2022
The effect of race/ethnicity on cancer-specific mortality after salvage radical prostatectomy
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.874945
- 1,507 views
- 2 citations
Original Research
Published on 18 Aug 2022
Evaluation of aliphatic acid metabolism in bladder cancer with the goal of guiding therapeutic treatment
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.930038
- 2,655 views
- 1 citation
Original Research
Published on 18 Aug 2022
Intravesical recurrence factors and outcome after radical nephroureterectomy for upper tract urothelial carcinoma: Multivariate analysis with propensity score matching
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.984014
- 1,793 views
- 3 citations
Mini Review
Published on 18 Aug 2022
Advancements in the treatment of metastatic hormone-sensitive prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.913438
- 4,843 views
- 4 citations
Original Research
Published on 18 Aug 2022
Machine learning model for the prediction of prostate cancer in patients with low prostate-specific antigen levels: A multicenter retrospective analysis
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.985940
- 3,435 views
- 2 citations
Review
Published on 18 Aug 2022
Role of PSMA PET-guided metastases-directed therapy in oligometastatic recurrent prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.929444
- 5,718 views
- 11 citations
Systematic Review
Published on 17 Aug 2022
A meta-analysis of clinicopathologic features that predict necrosis or fibrosis at post-chemotherapy retroperitoneal lymph node dissection in individuals receiving treatment for non-seminoma germ cell tumours
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.931509
- 2,230 views
- 3 citations